Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
CTI BIOPHARMA CORP (CTIC)
Sector: Healthcare; Industry: Biotechnology

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It develops PIXUVRI, a novel aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma; and pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase III clinical trials for the treatment of adult patients with myelofibrosis. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-01-07 ORBIMED ADVISORS LLC 10%-Owner Sell 2,000,000 $3.50 $7,000,000 No
2018-02-09 BVF PARTNERS L P/IL 10%-Owner Buy 6,333,333 $3.00 $18,999,999 Yes
2017-09-29 LOVE RICHARD L Director Sell 14,600 $3.21 $46,837 No
2016-06-24 BIANCO JAMES A President and CEO Sell 10,000 $0.37 $3,654 No
2016-05-27 BIANCO JAMES A President and CEO Sell 10,000 $0.45 $4,471 No
2016-04-29 BIANCO JAMES A President and CEO Sell 10,000 $0.52 $5,162 No
2016-03-28 BIANCO JAMES A President and CEO Sell 10,000 $0.49 $4,941 No
2016-03-21 BIANCO JAMES A President and CEO Sell 318,169 $0.55 $174,866 No
2016-03-04 Plunkett Matthew EVP, Chief Business Officer Sell 10,000 $0.59 $5,904 No
2016-02-26 BIANCO JAMES A President and CEO Sell 10,000 $0.63 $6,294 No
2016-02-26 SINGER JACK W EVP, Chief Scientific Officer Sell 15,000 $0.63 $9,517 No
2016-02-16 BIANCO JAMES A President and CEO Sell 100,000 $0.42 $41,920 No
2016-02-04 Plunkett Matthew EVP, Chief Business Officer Sell 10,000 $1.15 $11,538 No
2016-01-29 BIANCO JAMES A President and CEO Sell 10,000 $1.20 $12,012 No
2016-01-29 SINGER JACK W EVP, Chief Scientific Officer Sell 15,000 $1.18 $17,730 No
2016-01-08 BVF PARTNERS L P/IL 10%-Owner Buy 1,001,327 $1.22 $1,218,715 No
2016-01-04 Plunkett Matthew EVP, Chief Business Officer Sell 10,000 $1.21 $12,134 No
2015-12-30 BIANCO JAMES A President and CEO Sell 110,000 $1.26 $138,631 No
2015-12-18 SINGER JACK W EVP Global Medical Affairs Sell 15,000 $1.18 $17,673 No
2015-12-04 Plunkett Matthew EVP, Corporate Development Sell 10,000 $1.00 $9,969 No
2015-11-27 BIANCO JAMES A President and CEO Sell 10,000 $1.23 $12,253 No
2015-11-27 SINGER JACK W EVP, Global Medical Affairs Sell 15,000 $1.21 $18,157 No
2015-11-19 BIANCO LOUIS A EVP, Finance & Administration Sell 15,000 $1.13 $16,891 No
2015-11-04 Plunkett Matthew EVP, Corporate Development Sell 10,000 $1.38 $13,814 No
2015-10-30 BIANCO JAMES A President and CEO Sell 260,000 $1.35 $351,520 No
2015-10-29 BIANCO LOUIS A EVP, Finance & Administration Sell 10,000 $1.41 $14,073 No
2015-10-22 BIANCO LOUIS A EVP, Finance & Administration Sell 10,000 $1.58 $15,800 No
2015-10-23 SINGER JACK W EVP, Global Medical Affairs Sell 15,000 $1.62 $24,335 No
2015-10-05 Plunkett Matthew EVP, Corporate Development Sell 10,000 $1.52 $15,204 No
2015-09-30 NUDELMAN PHILLIP M PHD Director Sell 150,000 $1.45 $217,502 No

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.